Obesity causes dysfunction in major metabolic tissues. The glucose-fatty acid cycle, also known as the Randle hypothesis, provides the first basic concept for how elevated lipid levels in adiposity can cause dysregulated glucose metabolism and insulin resistance. Lipotoxicity is believed to be due to lipid overflow from adipocytes. Lipidomics studies in humans demonstrate that the lipid composition of serum is more closely resembles that of the liver, rather than white adipose tissue. Furthermore, the rhythmicity of hepatic metabolic function is known to couple the feeding behavior to biochemical reactions of substrate usage, suggesting that hepatic de novo lipogenesis also plays an important role in metabolic homeostasis. In the previous funding period, we proposed to examine the function of the nuclear receptor PPAR? in hepatic de novo lipogenesis. We find the expression of PPAR? and lipogenic genes, such as FAS, ACC1, ACC2 and SCD1, in mouse liver is under circadian regulation, being active in the dark (feeding) cycle. In liver-specific PPAR? knockout (LPPARDKO) mice, the up-regulation of ACC1 in the dark cycle is abolished, whereas the circadian pattern of FAS, ACC2 and SCD1 is shifted. Interestingly, the circadian rhythm of the hepatic lipogenic program correlates with the daily cycling of muscle fatty acid uptake/utilization, which is attenuated in LPPARDKO mice. Using unbiased, liquid chromatography-mass spectrometry (LC-MS) metabolomics approaches, we have identified 1-stearoyl-2- oleoyl-sn-glycero-3-phosphocholine (18:0-18:1 PC or SOPC), a phospholipid associated with PPAR?-regulated lipogenic program whose serum concentration peaks in the dark cycle. SOPC injection in mice promotes hepatic lipid synthesis/output and muscle FA utilization. In the renewal proposal, we will test the hypothesis that PPAR?-regulated lipogenic program modulates liver metabolism and muscle fatty acid utilization, in part, though SOPC. This research plan is innovative, as it describes a mechanism through which the circadian clock aligns the metabolic processes of feeding to peripheral energy substrate utilization. It is also on of the first studies, which use unbiased approaches to examine metabolomes using multiple mouse genetic models of metabolic diseases. The study is expected to lead to new areas of research and to have important clinical implication, as this novel lipid signaling may serve as a marker and a therapeutic target of metabolic diseases.
Lipid mediated pathological mechanisms in obesity-associated metabolic disorders have been under extensive investigation, since fat overflow primarily in the form of free fatty acids as a result of adipocyte hypertrophy can have negative metabolic impact. Recent lipidomics studies in humans have demonstrated that the lipid composition of serum is more closely related to that of the liver than of white adipose tissues, suggesting that the liver-lipogenic program plays an important role in modulation of systemic energy substrate utilization and homeostasis. The current project will investigate the mechanism through which hepatic fat synthesis affects postprandial fatty acid metabolism. We anticipate that results derived from this study will identify markers and therapeutic targets of metabolic diseases.
|McCarthy, Ryan C; Lu, Dah-Yuu; Alkhateeb, Ahmed et al. (2016) Characterization of a novel adult murine immortalized microglial cell line and its activation by amyloid-beta. J Neuroinflammation 13:21|
|Jacobi, David; Liu, Sihao; Burkewitz, Kristopher et al. (2015) Hepatic Bmal1 Regulates Rhythmic Mitochondrial Dynamics and Promotes Metabolic Fitness. Cell Metab 22:709-20|
|Knudsen, Nelson H; Lee, Chih-Hao (2014) IL-21 and IRF4: A complex partnership in immune and metabolic regulation. Diabetes 63:1838-40|
|Liu, Sihao; Alexander, Ryan K; Lee, Chih-Hao (2014) Lipid metabolites as metabolic messengers in inter-organ communication. Trends Endocrinol Metab 25:356-63|
|Liu, Sihao; Reilly, Shannon M; Lee, Chih-Hao (2013) Transcriptional repression of mitochondrial function in aging: a novel role for the silencing mediator of retinoid and thyroid hormone receptors co-repressor. Antioxid Redox Signal 19:299-309|
|Kim, Jonghan; Jia, Xuming; Buckett, Peter D et al. (2013) Iron loading impairs lipoprotein lipase activity and promotes hypertriglyceridemia. FASEB J 27:1657-63|
|Knudsen, Nelson H; Lee, Chih-Hao (2013) STAT4: an initiator of meta-inflammation in adipose tissue? Diabetes 62:4002-3|
|Stanya, Kristopher J; Jacobi, David; Liu, Sihao et al. (2013) Direct control of hepatic glucose production by interleukin-13 in mice. J Clin Invest 123:261-71|
|Liu, Sihao; Brown, Jonathan D; Stanya, Kristopher J et al. (2013) A diurnal serum lipid integrates hepatic lipogenesis and peripheral fatty acid use. Nature 502:550-4|
|Jia, Xuming; Kim, Jonghan; Veuthey, Tania et al. (2013) Glucose metabolism in the Belgrade rat, a model of iron-loading anemia. Am J Physiol Gastrointest Liver Physiol 304:G1095-102|
Showing the most recent 10 out of 20 publications